# Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

> **NCT01720836** · PHASE1,PHASE2 · RECRUITING · sponsor: **Olivera Finn** · enrollment: 30 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **BIOLOGICAL:** Vaccine + PolyICLC

## Key facts

- **NCT ID:** NCT01720836
- **Lead sponsor:** Olivera Finn
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2012-11
- **Primary completion:** 2027-10
- **Final completion:** 2032-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720836, "Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01720836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*